Chaudhry, Mohammed Suhail
Spahn, Jessica
Patel, Shilpen
Fuchs, Charles S.
Lauchle, Jennifer
Kolatkar, Nikheel
Richie, Nicole
Highsmith, Quita
McKenzie, Meghan
Bhagat, Ruma
Article History
First Online: 6 June 2022
Competing interests
: C.S.F. reports consulting roles for Amylin Pharmaceuticals, Astra-Zeneca, Bain Capital, CytomX Therapeutics, Daiichi-Sankyo, Eli Lilly, Entrinsic Health, Evolveimmune Therapeutics, Genentech, Merck and Taiho, served as a Director for CytomX Therapeutics, owns unexercised stock options for CytomX and Entrinsic Health, is a co-founder of Evolveimmune Therapeutics and has equity in this private company, and has provided expert testimony for Amylin Pharmaceuticals and Eli Lilly. All authors are employees of Roche Genentech and hold stock in Roche Genentech.
Free to read: This content has been made available to all.